Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction
First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue
AGORACOM NEWS FLASH
ATTENTION MEMBERS:
Tonight, we're giving our website a serious makeover.
So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.
In the event that you experience issues accessing the new site, please clear your browser's cookies and cache.
See You On The Other Side!
Discussion Forum: Awakn Life Sciences Corp.